Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination.
The need for efficient packaging and transportation solutions in the biopharmaceutical industry primarily drives this market. Strict government regulations for packaging of biopharma products is impacting the market positively. FDA regulations in the US mandate the use of high barrier packaging materials and sealants for several liquid drugs. These drugs require packaging that exhibit impermeability, and chemicals and heat resisting capabilities. Governments in developing countries such as China and India are continuously upgrading their industry standards for packaging to maintain quality, safety, and to reduce breakage/spillage and contamination. This trend is likely to boost the demand for advanced biopharma chain packaging materials and logistics services during the forecast period. North America is the largest market in terms of consumption of pharma packaging, accounting for a market share of about 30% in 2017. In 2017, APAC accounted for 22% of the global market and is estimated to be the fastest growing biopharma cold chain packaging market.
In 2018, the global BioPharma Cold Chain Packaging market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global BioPharma Cold Chain Packaging status, future forecast, growth opportunity, key market and key players. The study objectives are to present the BioPharma Cold Chain Packaging development in United States, Europe and China.
The key players covered in this study
Market segment by Type, the product can be split into
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global BioPharma Cold Chain Packaging status, future forecast, growth opportunity, key market and key players.
To present the BioPharma Cold Chain Packaging development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of BioPharma Cold Chain Packaging are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.